Investigation of the Effect of Proximal and Distal Adductor Canal Block in Knee Replacement Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorUmraniye Education and Research Hospital

About this trial

to investigate the effect of adductor canal block applied with two different approaches in the treatment of pain after TKA surgery on pain control and functional mobility.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Medications for unilateral TKA surgery

Patients aged 18-85

ASA 1-3

Disqualifiers

Patients under 18 years of age and over 85 years of age

Patients with ASA 4 and above

Patients with cognitive impairment

Patients with application site infection

Trial design

Design model

Parallel

Treatments tested in this trial

  • ADDUKTOR CANAL BLOCK

    Other intervention

    All patients who will undergo adductor canal block are sedated with midazolam 0.03 mg/kg in the preoperative preparation room, after standard monitoring. After 2-3 ml skin infiltration with 2% lidocaine under sterile conditions, a block is applied under USG guidance.To verify block success, sensory function is assessed by pinprick testing along the saphenous nerve distribution by comparing the pinprick sensation to the unaffected limb.All patients are monitored in the operating room and in a sitting position, 10-20 mg (2-4 ml) of heavy marcaine (0.5% bupivacaine hydrochloride and dextrose monohydrate) is applied to the subarachnoid space by entering the L3-4 or L4-5 space with a 25-gauge Whitrace needle.For postoperative multimodal analgesia, which is routinely applied to all patients, intravenous PCA (patient controlled analgesia )tramadol and paracetamol 10 mg / kg iv (8 hours apart) will be given.

  • CONTROL GROUP

    Other intervention

    No nerve block procedure is applied to patients.All patients are monitored in the operating room and in a sitting position, 10-20 mg (2-4 ml) of heavy marcaine (0.5% bupivacaine hydrochloride and dextrose monohydrate) is applied to the subarachnoid space by entering the L3-4 or L4-5 space with a 25-gauge Whitrace needle.For postoperative multimodal analgesia, which is routinely applied to all patients, intravenous PCA (patient controlled analgesia) tramadol 50 mg at 10 mg / hour basal rate after loading (20 mg bolus dose + 30 minutes lock time) and paracetamol 10 mg / kg iv (8 hours apart) will be given.

Treatment groups

78 Participants
are divided into 3 treatment groups
Group A: PROXİMAL ADDUKTOR CANAL BLOCK GROUPActive comparator 1 intervention
Group B: DİSTAL ADDUKTOR CANAL BLOCK GROUPActive comparator 1 intervention
Group C: CONTROL GROUPSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

VISUAL ANALOGUE SCALE(VAS)

VAS pain score was evaluated as "no pain" (score=0) and "worst pain" (score=10) and was divided into 3 groups according to the World Health Organization's pain intensity scale: score \<3 mild pain, 3-6 mild-moderate. degree pain and \>6 moderate-severe pain.

Time frame
POSTOPERATIVE 6, 12 AND 24 HOURS

Secondary outcomes

1

first mobilization time

The first postoperative mobilization hours of the patients will be recorded.

Time frame
within postoperative 24 hours
2

length of hospital stay

The time between patients' admission and discharge will be recorded.

Time frame
ONE WEEK
3

opioid use

Intravenous PCA will be applied to each patient and the total tramadol dose spent will be calculated.intravenous PCA (patient controlled analgesia) tramadol 50 mg at 10 mg / hour basal rate after loading (20 mg bolus dose + 30 minutes lock time)

Time frame
within postoperative 24 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.